Mark Badowsky

Mark Badowsky, CSM, MBA, PMP, currently serves as the Director of Program Management for Gene Therapy at Ultragenyx Pharmaceutical Inc. since September 2020. Previously, Mark held the role of Senior Project Manager at Biogen, leading high-priority neuroscience drug discovery programs and overseeing the transition of various assets from research to clinical stages. Mark's career also includes significant positions at Integrated Genetics, where responsibilities encompassed comprehensive program leadership in DNA sequencing projects, and at Fidelity Investments, where projects yielded substantial increases in customer service efficiency. Mark holds an MBA from Brigham Young University and a Bachelor of Science in Finance from Utah State University.